![15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ... 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...](https://onlinelibrary.wiley.com/cms/asset/5b383152-ecc4-449a-80f9-793cd22b93c4/ejh14102-fig-0001-m.jpg)
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...
![Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward](https://www.frontiersin.org/files/Articles/765097/fimmu-12-765097-HTML/image_m/fimmu-12-765097-g003.jpg)
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
![Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy](https://www.mdpi.com/cancers/cancers-14-05445/article_deploy/html/images/cancers-14-05445-g001-550.jpg)
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
![CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b5451e26-5ed7-43fd-bbd7-dffdfa376f00/eji5135-fig-0001-m.jpg)
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
![Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang](https://journals.sagepub.com/cms/10.1177/0300060518783083/asset/images/large/10.1177_0300060518783083-fig3.jpeg)
Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang
The defect of B cell development in CD19-Cre + PDK1 flox/flox mice is... | Download Scientific Diagram
![Elevated peripheral blood B lymphocytes and CD3+CD4‑CD8‑ T lymphocytes in patients with non‑small cell lung cancer: A preliminary study on peripheral immune profile Elevated peripheral blood B lymphocytes and CD3+CD4‑CD8‑ T lymphocytes in patients with non‑small cell lung cancer: A preliminary study on peripheral immune profile](https://www.spandidos-publications.com/article_images/ol/15/6/ol-15-06-8387-g00.jpg)
Elevated peripheral blood B lymphocytes and CD3+CD4‑CD8‑ T lymphocytes in patients with non‑small cell lung cancer: A preliminary study on peripheral immune profile
![The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4817-4/MediaObjects/12885_2018_4817_Fig1_HTML.png)
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
![CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes | Science Advances CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes | Science Advances](https://www.science.org/cms/10.1126/sciadv.adf0661/asset/35eff86f-2a83-40ab-971b-ebd72df3f992/assets/images/large/sciadv.adf0661-f1.jpg)
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes | Science Advances
![Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward](https://www.frontiersin.org/files/MyHome%20Article%20Library/765097/765097_Thumb_400.jpg)
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
![Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets](https://pub.mdpi-res.com/cells/cells-09-02633/article_deploy/html/images/cells-09-02633-ag.png?1607416730)
Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
![Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma](https://www.frontiersin.org/files/Articles/561200/fimmu-11-01941-HTML-r1/image_m/fimmu-11-01941-g004.jpg)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
![CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8c433efe-92ec-4327-adfb-d287ac58065d/eji5135-fig-0002-m.jpg)
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
![Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram](https://www.researchgate.net/profile/Ting-Jin-13/publication/296688930/figure/fig4/AS:565477178712064@1511831673260/Percentages-of-CD4-IL10-T-cells-and-CD19-IL10-B-cells-increase-and-CD19-B_Q320.jpg)
Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram
![Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection | Leukemia Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.leu.2403559/MediaObjects/41375_2005_Article_BF2403559_Fig1_HTML.jpg)
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection | Leukemia
![Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma](https://www.frontiersin.org/files/Articles/561200/fimmu-11-01941-HTML-r1/image_m/fimmu-11-01941-g001.jpg)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
![Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies - ScienceDirect Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120343068-gr2.jpg)
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies - ScienceDirect
![Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia - Soma - 2015 - Cytometry Part B: Clinical Cytometry - Wiley Online Library Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia - Soma - 2015 - Cytometry Part B: Clinical Cytometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0f116632-5f9e-4ef4-bed1-4ed739bdc85e/cytob21179-fig-0001-m.jpg)
Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia - Soma - 2015 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
![Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0161589015000887-gr1.jpg)
Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect
![Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy](https://www.mdpi.com/cancers/cancers-14-05445/article_deploy/html/images/cancers-14-05445-g001.png)